The medicine is constantly evolving with new technologies, and a startup has taken a major step by developing a mini robot that could end the need for traditional endoscopies.
Endiaxinnovative company, presented PillBota small robotic pill that enables real-time visualization of the inside of the human body, revolutionizing current diagnostic methods.
Alex Luebke, co-founder and engineer at Endiatx, staged a daring demonstration by ingesting one of these pills live during a TED talk. As the PillBot’s tiny internal camera captured images, they were displayed on a giant screengiving the public a real-time look at Luebke’s body.
This impressive demonstration not only demonstrated the safety and effectiveness of the device, but also attracted worldwide attention, amassing more than 44 million views in less than ten days.
Unpublished live broadcast and in a TED talk
During the lecture, Vivek Kumbhari, professor of medicine at the Mayo Clinic and co-founder of Endiatx, was in charge of transmitting live images of Luebke’s body to attendees.
Pill, Wirelessly controlled, it traveled through the businessman’s stomach and esophagus, showing every internal detail. Luebke noted that historically, the only way to explore the inside of the human body was through invasive and rudimentary surgeries. Now, thanks to the PillBot micro-robotics, it is possible to perform these examinations in a less invasive way and with greater precision.
Dr. Kumbhari added that The PillBot has the ability to acquire images comparable to those of a traditional endoscope, but without the inconvenience of an invasive procedure. If widely used, this technology could change the way medical diagnoses are made, improve the patient experience and reduce the risks associated with conventional surgeries.
What is PillBot, a mini robot that ends endoscopy
Endiatx has come a long way to perfect the PillBot, going through about 50 previous versions to arrive at the current design, which is the size of a regular pill. This development required an approximate investment of 28 billion Colombian pesos.
Torrey Smith, the company’s founder, tested the prototype 43 times, demonstrating his commitment to innovation and product safety. PillBot is currently in phase three clinical trials, a critical phase before the planned commercial launch in 2026.
The design of the PillBot stands out multi-pump propulsion systemwhich allows the device to move in different directions by emitting streams of fluid without harming the patient.
Except, It is equipped with a camera that transmits high-definition video at 2.3 megapixels per second and LED lights, making it easy for the doctor to monitor the transmission wirelessly.. These features overcome the limitations of traditional endoscopies and offer a more advanced and less invasive alternative.
Endiatx plans to continue improving PillBot’s image quality before its final commercialization. With current features, This mini robot promises to revolutionize the field of gastroenterologyoffering innovative and effective solutions for internal diagnoses without the need for invasive interventions.
More news in EL TIEMPO
*This content was transcribed with the help of artificial intelligence based on information from La Nación and was checked by a journalist and an editor.
